TURKISH JOURNAL OF UROLOGY, vol.47, no.6, pp.495-501, 2021 (Journal Indexed in ESCI)
Article / Article
Title of Journal :
TURKISH JOURNAL OF UROLOGY
Androgen deprivation therapy, prostate cancer, SARS-CoV-2, TMPRSS-2, PROSTATE-CANCER, COVID-19, TMPRSS2, RISK
Objective: The protective effect of androgen deprivation therapy (ADT) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel hypothesis. ADT may protect patients with prostate cancer through the inhibition of androgen receptor-dependent transmembrane serine protease type 2. We analyzed the role of ADT on SARS-CoV-2 infection risk and disease severity.